ITCI

Intra-Cellular Therapies

131.87

-0.05-0.04%

Suspension19:40 04/01 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE131.90/131.92

TODAY RANGE131.63-131.98

VOL16.06M

MARKET CAP14.05B

52 WEEK RANGE64.09-131.98

AVG VOL (3M)3.49M

% TURNOVER15.08%

TURNOVER--

P/E (TTM)-182.1157

% RANGE0.11%

EPS(TTM)-0.7241

P/E(FORWARD)538.24

P/B12.20

BVPS10.81

DIVIDEND--

P/S20.58

BETA--

DIV YIELD0.00%

FREE FLOAT MKT CAP13.50B

SHARES OUTSTANDING106.52M

NEXT EARNINGS05/05-05/09

FREE FLOAT102.35M

LOT SIZE1

EX-DIV DATE--

Feeds

News

Press Releases

Financial Reports

Profile

Same Industry

Name/Symbol

Change%

Price

McKesson

MCK

+0.10%

673.69

Biogen Inc

BIIB

-3.52%

132.03

Amgen Inc

AMGN

-1.49%

306.92

Shire

SHPG

179.20

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

-5.20%

0.0474

Lilly Eli & Co

LLY

-2.50%

805.23

Celgene

CELG

108.24

Therapeuticsmd Inc

TXMD

+5.95%

0.9800

Johnson & Johnson

JNJ

-7.59%

153.25

Abbvie Inc

ABBV

-1.55%

206.27

Zoetis Inc

ZTS

-1.66%

161.91

Gilead Sciences Inc

GILD

-0.69%

111.28

Novo-Nordisk A/S

NVO

-2.03%

68.03

Bristol-Myers Squibb Co

BMY

-2.36%

59.55

Alexion Pharms

ALXN

+1.70%

182.50

Pfizer

PFE

-3.16%

24.54

Sanofi FR

SNY

-2.02%

54.34

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-1.68%

109.61

Dr Reddys Labs

RDY

-0.23%

13.16

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.